NCT07213817
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07213817
Title A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Ipsen
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Yale Cancer Center-Yale University NOT_YET_RECRUITING New Haven Connecticut 06510 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Sidney Kimmel Cancer Center NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
Centre Leon Berard NOT_YET_RECRUITING Lyon France Details
Institut de Cancerologie de l'Ouest (ICO)- CRLCC Rene Gauducheau NOT_YET_RECRUITING Saint-Herblain France Details
Gustave Roussy Cancer Campus Grand Paris- (Institut de Cancerologie Gustave-Roussy) NOT_YET_RECRUITING Villejuif France Details
Hospital Universitari Vall d'Hebron NOT_YET_RECRUITING Barcelona Spain Details
NEXT Quiron-Barcelona NOT_YET_RECRUITING Barcelona Spain Details
START Madrid CIOCC Hospital Universitario HM Sanchinarro NOT_YET_RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field